Axol and StrataStem link up for Alzheimer's disease trial
Companies will incorporate cells and technology to create a ‘clinical trial in a dish’ - News - PharmaTimes
Stay updated with breaking news from Axol Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Companies will incorporate cells and technology to create a ‘clinical trial in a dish’ - News - PharmaTimes
/PRNewswire/ -- The "Global Cardiovascular Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's...
DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global induced pluripotent stem cell (ipsc) market will grow from $2.69 billion in 2022 to $2.97 billion in 2023 at a compound annual growth rate (CAGR) of 10.5...
/PRNewswire/ -- The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023" report has been added to...
/PRNewswire/ -- Polaris Market Research recently published [115+ Pages] research report on "Cell Reprogramming Market Share, Size, Trends, Industry Analysis...